key: cord-0818925-l7m2tl03 authors: Mumoli, Nicola; Florian, Clarissa; Cei, Marco; Evangelista, Isabella; Colombo, Alessandra; Razionale, Giancarlo; Moroni, Luca; Mazzone, Antonino title: Palliative care in a COVID-19 Internal Medicine Ward: a preliminary report date: 2021-02-16 journal: Int J Infect Dis DOI: 10.1016/j.ijid.2021.02.053 sha: 948299a9ae6d6de1c3c4168e5184fa416fe6f354 doc_id: 818925 cord_uid: l7m2tl03 nan As of February 2020, the epidemic of Coronavirus-19 disease in Italy, and more than anywhere else in the region of Lombardy, has created the necessity for supporting clinicians in decision making based on the limited data available in the literature (Grasselli et al., 2020 ). In the current pandemic emergency, increased attention has given to treating symptoms that cause suffering; the role of palliative care in the management of patients with Covid-19 is therefore of great importance (Radbruch et al. 2020 ). Relevant studies (Zhou et Moreover, patients with poor prognosis undergo a phase lasting for hours or days with severe symptoms, such as dyspnea requiring mechanical ventilation (either invasive or non-invasive). The vast majority of these patients usually require a palliative approach (Maglio et al., 2020) . Due to the shortage of intensive care beds and ventilators, physicians are responsible for evaluating the clinical aspects related to prognosis (symptoms, blood chemistry, gas analysis, and imaging), as well as the age and the presence of comorbidities, to define the degree of appropriate therapeutic intensity (Vergano et al., 2020) . While this task has caused considerable distress for clinicians involved in triage and assuming difficult decisions, such an evaluation protected patients from treatments that do not lead to substantial benefits; helps to identify those who need a palliative approach only, and promotes rational and ethical use of health care resources. The knowledge of meaningful, although preliminary, palliative care experiences in patients with COVID-19 is precious, considering the scarce literature existing. The setting of this study was a ward of Internal Medicine (Department of Internal Medicine, Magenta Hospital, Magenta, Milan, Lombardy, Italy) dedicated to symptomatic Covid-19 patients. The work of PCP focused on a daily presence, at first as more of an observer and then gradually more proactively, and defined shared operational procedures in the following areas:  defining the criteria for identifying a Covid-19 patient who should start palliative treatment;  sharing the decision-making process with hospital physicians (intensivist and internist) and the triage team;  managing symptoms such as anxiety and stress regarding the intolerance to respiratory devices;  administering deep continuous palliative sedation at the end of life;  choosing drugs and how to administer them;  reporting to and communicating with patients and family members;  protecting the self-determination of the patient. The treatment protocols were left to the discretion of the physician in charge. Palliative consultation was also requested by the staff as per protocol. In brief, the criteria for referring patients to a palliative care physician or to undergo palliative care were:  cases clinically classified as serious and critical, that cannot undergo intensive care treatment, because they have been judged inappropriate or excessive.  patients symptomatic for dyspnoea, psycho-motor agitation/restlessness, pain, insomnia, anxiety/panic stress.  patients who are intolerant to C-PAP, in particular, to helmet (used in most cases) or to the high levels of oxygen therapy with reservoir, and therefore the need to increase compliance to these treatments.  patients who decide not to begin or to suspend intensive care. We recorded data regarding age, gender, length of stay, type of discharge (dead or alive, and transfer to long-term or hospice facilities). The principal reason for counseling was controlling symptoms (54%) and 12% deal with the end of life management. The prevalent symptom, among those which led to the counseling, was restlessness/agitation (41%), followed by emotional issues (26%) such as anxiety, fear, and demoralization. In only 20% of cases, dyspnoea was the reason for symptomatic treatment and in 13% of cases, counseling was due to less frequent symptoms such as myalgia/arthralgia and pain. Pharmacological treatments most frequently used to deal with symptoms are shown in table 2. The PCP was also heavily involved in communication and reporting to family members, who were not allowed to see their loved ones. We report a preliminary experience in the identification of Covid-19 patients requiring palliative care, and how this was accomplished in an Internal Medicine ward in Italy, during the first wave of are useless since the patient will, in any case, die. What is then needed is to modify treatments, suspend specific therapies (above all antiviral, antibiotic, and anti-thrombotic) and inappropriate diagnostic procedures (ie. strict monitoring of blood tests and gas analyses). It is, therefore, necessary to pay particular attention to the evaluation and the management of not only physical but also psychological symptoms (ie. stress, anxiety, delirium, and depression) and carry out the overall care of the patient and his family (Maglio et al., 2020) . In our COVID-19 Internal Medicine wards a multidisciplinary team of intensivists, internists, pulmonologists, infectious disease specialists, and palliative care physicians discussed daily the strategies for personalizing treatment of critical patients. In our experience, one-fourth of patients were managed by the PCP for at least two days. Mortality in such patients was very high (two-thirds). We believe that such high numbers support the decision to include a PCP in the staff that takes care of this type of severely sick patients. Some peculiar features of this experience were: -the characteristic of the pathology in terms of its seriousness and rapid progression which leads to "emergency palliative care"; -the role of the PCP as part of the decision-making team and not just as an end of life specialist. A model which is similar to that used in simultaneous care which is a flexible, dynamic, and integrated approach. -a renewed model due to the need to 'invent' strategies, identify adequate criteria and methods of intervention to propose and apply. A large number of hospitalized Covid-19 patients are at high risk of clinical deterioration and death. This leads to the opportunity to integrate a palliative physician into the staff, who treat these patients. There is an urgent need for protocol standardization and formal trials to verify the effectiveness of this approach. J o u r n a l P r e -p r o o f Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region The key role of palliative care in response to the COVID-19 tsunami of suffering Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study Hospitalization and Mortality among Black Patients and White Patients with Covid-19 Coronavirus disease 2019 in elderly patients: Characteristics and prognostic factors based on 4-week follow-up Ethical guides, criteria for admission in intensive care, palliative care. Multi-society recommendations for allocation of resources during the COVID-19 pandemic Clinical ethics recommendations for the allocation of intensive care treatments in exceptional, resource-limited circumstances: the Italian perspective during the COVID-19 epidemic The SARS-CoV-2 outbreak: What we know Ethical, deontologic and legal considerations about SIAARTI Document COVID-19: guidance on palliative care from a European Respiratory Society international task force Funding: None declared.Ethical approval: The local institutional review board approved this study and waived the need for informed consent. NM: participated in the study design and coordination, collated and analysed the data, and drafted the manuscript; CF, LM, IE, GR: participated in the study design and data collection; AM, MC: participated in the study design and helped draft the manuscript. The authors state that they have no conflicts of interest.